These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8901002)
21. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. Rai SN; Yadav SK; Singh D; Singh SP J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287 [TBL] [Abstract][Full Text] [Related]
22. Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase. Fornai F; Carrì MT; Ferri A; Paolucci E; Prisco S; Bernardi G; Rotilio G; Mercuri NB Neurosci Lett; 2002 Jun; 325(2):124-8. PubMed ID: 12044637 [TBL] [Abstract][Full Text] [Related]
23. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent. Freyaldenhoven TE; Cadet JL; Ali SF Brain Res; 1996 Oct; 735(2):232-8. PubMed ID: 8911661 [TBL] [Abstract][Full Text] [Related]
24. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Sonsalla PK; Jochnowitz ND; Zeevalk GD; Oostveen JA; Hall ED Brain Res; 1996 Oct; 738(1):172-5. PubMed ID: 8949944 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. Mohanakumar KP; Muralikrishnan D; Thomas B Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035 [TBL] [Abstract][Full Text] [Related]
27. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity. Oeckl P; Ferger B Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149 [TBL] [Abstract][Full Text] [Related]
28. The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Dluzen DE; Kefalas G Brain Res; 1996 Nov; 741(1-2):215-9. PubMed ID: 9001725 [TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice. Kurosaki R; Muramatsu Y; Imai Y; Kato H; Araki T Neurol Res; 2004 Sep; 26(6):644-57. PubMed ID: 15327754 [TBL] [Abstract][Full Text] [Related]
30. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135 [TBL] [Abstract][Full Text] [Related]
31. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655 [TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of riluzole in MPTP-treated mice. Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056 [TBL] [Abstract][Full Text] [Related]
34. Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice. Vaglini F; Pardini C; Bonuccelli U; Maggio R; Corsini GU Brain Res; 2003 May; 973(2):298-302. PubMed ID: 12738074 [TBL] [Abstract][Full Text] [Related]
35. Participation of nucleus entopeduncularis in motor instrumental reflex and entopeduncular influences on motor thalamic nuclei in normal and MPTP-treated cats. Voloshin MYa ; Shevko GN; Lukhanina EP; Kolomiets BP Neuroscience; 1993 Apr; 53(3):845-54. PubMed ID: 8098141 [TBL] [Abstract][Full Text] [Related]
36. Screening of novel pentacyclo-undecylamines for neuroprotective activity. Geldenhuys WJ; Terre'Blanche G; Van der Schyf CJ; Malan SF Eur J Pharmacol; 2003 Jan; 458(1-2):73-9. PubMed ID: 12498909 [TBL] [Abstract][Full Text] [Related]
37. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614 [TBL] [Abstract][Full Text] [Related]
38. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444 [TBL] [Abstract][Full Text] [Related]
39. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Rojo AI; Cavada C; de Sagarra MR; Cuadrado A Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941 [TBL] [Abstract][Full Text] [Related]
40. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]